StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Processa Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2016 was 100.0%. For fiscal 2016 it was 100.0%, against -11.0% the year before. The highest annual figure on record is 100.0% in fiscal 2016.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2016Dec 31, 2016100.0%+111.0
FY2015Dec 31, 2015-11.0%−48.7
FY2014Dec 31, 201437.7%−2.2
FY2013Dec 31, 201339.8%+9.2
FY2012Dec 31, 201230.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2016Mar 31, 2016100.0%–

More Processa Pharmaceuticals figures

See a number that looks wrong?